Tesamorelin Follistatin Myostatin Bodybuilding Releasing Polypeptide Hormones CAS 218949-48-5

Tesamorelin Follistatin Myostatin Bodybuilding Releasing Polypeptide Hormones CAS 218949-48-5

Cas No. 218949-48-5

Synonyms: Tesamorelin

Molecular Formula: C211H366N72O67S1

MW: 5135.89

Sequence:

Purity: >98%

Bacterial Endotoxins: < 5EU/mg

Description:

Tesamorelin, (formerly known as TH9507), is a type of peptide called a growth hormone-releasing factor (GHRF).

Tesamorelin / Egrifta is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy, which consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group. Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism. Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss.

Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism. Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss. Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral body fat).

Function:

GHRF causes growth hormone to be created and spread in the body, which helps increase metabolism, reduce belly fat, improve body shape, and use of energy. Tesamorelin (formerly known as TH9507) is a synthetic growth hormone-releasing factor that stimulates the pituitary gland in the brain to secrete growth hormone; this indirect approach appears to maintain more stable, natural levels, like CJC-1295 DAC.Clinical trials have shown that tesamorelin significantly reduces abdominal fat with fewer side effects than human growth hormone itself, although abdominal fat may return after the Tesamorlein is discontinued (depending upon the individual). Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals as well as similarly reducing abdominal fat in NON-HIV-Infected individuals.

Usage:

Tesamorelin is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces growth hormone (GH) in a specific and physiological manner. To date, clinical studies suggest that Tesamorelin reduces visceral fat in HIV-infected patients with abdominal lipo-hypertrophy as well as reducing abdominal fat in all individuals studied.

Applications:

Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.

Tesamorelin used to reduce belly fat in HIV patients, could be the ultimate key for bodybuilders who have trouble getting ripped abs. Tesamorelin reduces visceral fat in HIV-infected patients with abdominal lipo-hypertrophy as well as reducing abdominal fat in all individuals studied.

Tesamorelin used by Bodybuilders take for Fat Loss, that can help bodybuilders achieve major muscle gains and cut fat quickly and efficiently.

Related products: